65 results
8-K
EX-99.1
INSM
Insmed Incorporated
4 Jun 24
Regulation FD Disclosure
7:00am
, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ. Changing demographics, epidemiology, and survival of incident
8-K
EX-1.1
INSM
Insmed Incorporated
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
on Nasdaq; (v) the filing fees incident to, and the fees and disbursements of counsel for the Underwriters in connection with, any required review … and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section
8-K
EX-10.1
INSM
Insmed Incorporated
22 Feb 24
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:58am
with the provisions of Section 11 hereunder, will pay or cause to be paid all expenses incident to the performance of the Company’s obligations hereunder
S-3ASR
INSM
Insmed Incorporated
19 May 23
Automatic shelf registration
4:20pm
shareholder of up to 27,793 shares of common stock.
We are required to pay all fees and expenses incident to the registration of the securities to be offered
8-K
EX-1.1
m6o0ro1nlv2p9
20 Oct 22
Insmed Announces Strategic Financings Totaling $775 Million
4:01pm
8-K
EX-1.2
rkalvsb0tl
13 May 21
Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
7:47am
8-K
EX-1.1
00z2 uqelennic
13 May 21
Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
7:47am
8-K
EX-10.1
v7rkoy 16
25 Feb 21
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:29am
8-K
EX-1.1
4hknqi 7q
7 May 20
Insmed Announces Proposed Public Offering of Common Stock
8:31am
424B5
461dte5mm7
5 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-1.1
flff0dcznj62yqo2y1wl
24 May 19
Insmed Announces Proposed Public Offering of Common Stock
6:01am